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1. Abstract
Blood flow is normally controlled by individual tissues, providing 
the appropriate rate of oxygen delivery (DO2). Cardiac output is 
the result of the addition of all tissue blood flows. Cardiac output 
is therefore controlled at the tissues, not heart or brain. Complica-
tions in anesthesia are from lowered DO2 due to venous relaxation 
lowering arterial pressure. Arterial blood pressure depends on ar-
terial volume, in turn depending on total blood volume and venous 
volume control. The usual idea, arterial pressure is controlled by 
arteriolar tone in therefore incorrect. The bases of these assertions, 
are outlined in sections 1 and 2, and implications in section 3. 
Further interesting surgical phenomena receive attention, includ-
ing carotid endarterectomy effects on hypertension, and potential 
improvement in treatment of myocardial ischemia. Circulatory 
theory is here corrected – a paradigm shift of great importance to 
medicine and surgery.
SECTION 1
2. Matching Tissue Oxygen Supply to The Rate of Oxygen 
Consumption is The Top Priority of The Circulation
2.1. Origins of the Utilization of Oxygen
Energy is an essential feature of living things, required not only for 
movement, cerebration, digestion etc. but also to sustain molecular 
organization within cells. Muscular activity and varying activity in 
other tissues, such as brain, heart and gut, and their maintenance, 
all require provision of energy. The earliest living things were single 
cells and for them energy was obtained, in the main, from molec-
ular interactions which did not utilize oxygen (anaerobic respira-
tion, e.g. methanogens, which react hydrogen with carbon dioxide 
making methane as a waste product).
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Energy yield was less than can be obtained from interaction with 
oxygen which is, nevertheless, highly toxic, from its ready conver-
sion to biochemically dangerous free radicals. Eventually certain 
bacteria evolved with the ability to utilize oxygen in energy gen-
erating reactions which largely avoided free radical release [1, 2].
Multicellular organisms were initiated 600 million years ago when 
an oxygen capable bacterium was incorporated into a second type 
of unicellular organism – a member of the archaea [1, 3]. The ox-
ygen capable bacteria in these new combined organisms became 
mitochondria. Multicellularity became possible for the new com-
bined organisms. Their evolution included branches where, with 
increasing size, circulation evolved such that oxygen could be 
transported from the atmosphere to the tissues. Hence, evolution 
sub-served circulatory delivery of oxygen, appropriate to oxygen 
consumption by the mitochondria. In this section evidence is given 
for the precision regulation of blood flow to provide the appropri-
ate oxygen supply to major tissues. These include, specifically,
Skeletal muscle, heart and brain, and evidence for whole body oxy-
gen supply, provided by appropriate cardiac output, the total of the 
individually regulated tissue blood flows.
2.2. Cardiac Output in Exercise is Independent of Cardiac In-
nervation
Total circulatory blood flow is the sum of blood flows from every 
tissue. All blood flow converges on the heart. “The heart puts out 
what it receives” [4]. Hence, whole body blood flow becomes the 
Cardiac Output (CO). Blood flow to skeletal muscle increases in 
exercise, resulting in the increase in cardiac output. The fact that 
tissues control their own blood flow is well illustrated by the ex-
perimental work of Donald and Shepherd [5]. Conscious mongrel 
dogs were instrumented for continuous measurement of cardiac 
function and Figure 1 shows the cardiac output resulting from 4 
minutes exercise. On the left (A) is the result where the dogs exer-
cised with intact cardiac innervation. On the right (B) is shown the 
result after recovery from full cardiac autonomic ablation (method 
of Cooper et al, [6]. Although the response after denervation was 
less regular the cardiac output increase during exercise was basi-
cally the same as in the normal dogs. The difference was that the 
heart rate increase had largely been lost. Since the skeletal muscle 
blood flow had increased to the same extent, but with longer filling 
periods, stroke volume was correspondingly increased (lower re-
cord in B). These findings are consistent with the local regulation of 
increased blood flow through the exercising skeletal muscle during 
exercise, and of the appropriate rate of oxygen supply at the site of 
the increased rate of oxygen consumption.
2.3. Changes in Cardiac Output Occur in Proportion to Chang-
es in Oxygen Consumption
With increasing work rates, and corresponding increases in the 
rate of oxygen consumption (VO2), normal subjects increase their 
cardiac output in direct proportion to the increase in VO2 [7, 8]. 
This is illustrated in Figure 2. Normally active subjects and athletes 
increase CO with the same linear relationship to VO2. For athletes 
the line continues above and beyond the maximum for non-ath-
letes (up to around 4 litres a minute to 5 l min-1 or more – 20 
times the resting value). With heart disease there may be failure to 
proceed up the normal exercise line – mitral stenosis in the figure.
The proportional increase in CO means there is also proportional 
increase in DO2. Hence, DO2 increases in proportion to increases 
in VO2.
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Figure 1. The uppermost traces are of cardiac output (CO), the middle traces heart 
rate (HR) and the lower traces stroke volume (SV). On the left (A) recordings were 
made in intact dogs, on the right (B) following recovery after cardiac autonomic 
denervation. After Donald and Shepherd (5) with permission (American Journal of 
Physiology – legacy collection).
Figure 2. The figure (after Rowell, (8)) shows that there is a very similar relationship 
between CO and VO2 for normal subjects and athletes. The departure from the 
common line only occurs with disease (here, mitral stenosis).
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Hence exercising muscle DO2 (DO2m) also increases in direct pro-
portion to the increase in VO2. In the normal subject the increase 
in VO2 is presumably skeletal muscle VO2 (VO2m) so for normal 
exercise there is a constant DO2m:VO2m ratio. This also means that 
the inverse, the rate of oxygen extraction (VO2m/DO2m), is constant, 
under normal circumstances. Whether constant oxygen extraction 
of exercising muscle is also the case with low arterial oxygen con-
tent (CaO2) was investigated by Wolff, [9]. This followed a period 
of informal investigations concerning the validity or otherwise of 
CO measurement which showed that DO2, calculated from arterial 
oxygen content (CaO2) times CO values given in the literature, of-
ten gave supposed DO2 values less than measured VO2; an obvious 
error. Guyton et al [7] pointed out that accurate measurement of 
CO could be obtained from the direct Fick method or dye dilution. 
Also, that other methods gave values often only 2/3rd correct values.
The formal study [9] analyzed results from two papers [10, 11] 
where supine exercise enabled study of a limited muscle group 
(thigh extensor) and included measurement of exercising muscle 
venous oxygen content (CvO2) via a retrograde femoral venous 
catheter. CO was measured by dye dilution and gave resting values 
above assumed norms in the literature of 5 litres per minute see 
(Table 1). One of the two studies [10] included rest, exercise at 30 
watts (w) as well as maximum and half maximum intensity. This 
sequence was completed at both normal CaO2 and low CaO2 (from 
normo-volaemic anaemia). In the second study, [11] resting and 
30w exercise were undertaken with normal CaO2 and with 3 low 
CaO2 conditions: anaemia, hypoxia and combined anaemia and 
hypoxia. The results from the two studies suggested constancy of 
exercising muscle oxygen extraction (or the inverse – DO2/VO2). 
It is shown here that this important finding can be more strong-
ly supported by further examination, presented here. The findings 
and derivation are given in two tables (Table 1 measured values and 
Table 2 derived values), making the data available to the reader for 
full assessment. The importance of the findings is that they demon-
strate conclusively that cardiac output, at least for exercise, is deter-
mined at individual tissue level (skeletal muscle, in this case), and 
is simply the sum of the tissue blood flows converging as the input 
to the heart; also, that the individual tissue blood flows sustain the 
rate of DO2 appropriate to the ongoing VO2. Here, we consider the 
evidence for exercising skeletal muscle. We then show that appro-
priate DO2 is also provided for cardiac and cerebral tissues in the 
face of hypoxia and metabolic rate change.
2.4. The Rate of Oxygen Delivery to Sub-Maximally Exercising 
Muscle is Sustained With Moderate Anaemia and Hypoxia
These comprehensive measurements in Table 1 enable calcula-
tion of the oxygen consumption by the exercising skeletal mus-
cle (VO2m), and its blood flow (Qm) and rate of oxygen delivery 
(DO2m). The oxygen consumption is taken to be the excess during 
exercise above the resting value. The exercising skeletal muscle 
blood flow (derived from the Fick equation), is VO2m divided by 
the arterio-venous oxygen content difference (Δa-vO2). Although 
the authors of the papers made measurements of limb blood flow 
which correlate with those from the Fick equation, the latter have 
been utilized here since it is only them which are compatible with 
all the measured and derived variables.
Table 1: Measurements from two studies (10, 11) mentioned above.
MEASURED




0 0.349 0.1901 0.0965 6.27
Ex 30 0.801 0.1905 0.0647 10.25
Ex 73 1.425 0.191 0.0565 14.73
Exmax 143 2.753 0.2025 0.0528 20.35
Rest
Anaemia
0 0.411 0.1511 0.0666 7.72
Ex 30 0.89 0.1531 0.0502 12.05
Ex 55 1.188 0.1538 0.0489 13.69
Exmax 118 2.322 0.1623 0.0407 21.3
11
Rest Normal O2 0 0.35 0.1903 0.0958  Ex 30 0.84 0.1903 0.0639 10.2
Rest Anaemia 0 0.4 0.1507 0.0668  Ex 30 0.88 0.1513 0.0495 12
Rest Hypoxia 0 0.3 0.1624 0.0792  Ex 30 0.88 0.1507 0.0508 11
Rest Anaem&Hypox 0 0.38 0.131 0.0604  Ex 30 0.91 0.1147 0.0316 12.6
Figure 3, on the left, shows a schematic for exercise with normal 
oxygenation; the middle section shows the relationship of exercis-
ing muscle blood flow (Qm) to VO2m for both the normal and the 
anaemic (normo-volaemic) subjects. There is greater blood flow 
where CaO2 is reduced. On the right DO2m (DO2 for muscle) is 
plotted for both the anaemic and the normally oxygenated sub-
jects. Since these two plots follow the same trend, there is confir-
mation that, at least for the given degree of anaemia, DO2m values 
are sustained over this range of VO2m at the same values as for the 
normally oxygenated subjects. In other words, there is exercising 
muscle tissue compensation for the low CaO2, as a result of a tissue 
mediated increase in Qm. The mechanism for this precision adjust-
ment is, at present, unknown.
DO2m and Qm were calculated from the variables in Table 1 and 
appear with further derived variables in Table 2.
On derivation of variables in Table 2.
VO2m, exercising muscle VO2, is derived by subtraction of the rest 
value from the exercise value (Ex-rest); DO2m is Qm times CaO2; 
Δa-vO2 is the arterio-venous oxygen content difference. Qm, mus-
cle blood flow, is derived as VO2m/Δa-vO2 (from the Fick equa-
tion), Em% is the percentage oxygen extraction, here derived from 
the ratio of Δa-vO2 to CaO2. Oxygen extraction is also VO2m/
DO2m and gives the same answer since it is (Qm x Δa-vO2)/(Qm x 
CaO2) and Qm cancels out.
We are now in a position to examine the relationship of the oxygen 
extraction, expressed as a percentage (E%), to arterial oxygen con-
tent (left hand panel of Figure 4, and to the work rate (watts – mid-
dle panel). The inverse – DO2m/VO2m is shown (right hand panel) 
for 30 watt exercise plotted against CaO2.
VO2 and CO are in litres per minute, CaO2 and CvO2 are expressed as 
volumes of oxygen per unit volume of blood (i.e. in the same units).
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Figure 3: The left panel shows a schematic of the normal relationship between CO and VO2, with assumptions as to exercising muscle oxygen consumption (VO2m) and 
blood flow (Qm). For normal oxygenation the exercising blood flow (Qm) is as shown. With low CaO2 there may be greater muscle blood flow. The middle panel shows 
the exercising muscle blood flow (Qm) plotted against exercising muscle oxygen consumption (VO2m). Qm is greater for low CaO2 than for normal CaO2. As shown in the 
right hand panel, this excess blood flow compensates for low CaO2 and sustains the same DO2m as for normal oxygenation.
Table 2: Derivation of variables in table 2
 DERIVED (Ex-rest)   ΔVO2/Δa-v Qm*CaO2 (Ca-Cv)/Ca
Watts  VO2m CaO2 Δa-vO2 Qm DO2m Em%
0
Normal
 0.1901 0.0936   49.2
30 0.452 0.1905 0.1258 3.59 0.684 66
73 1.076 0.191 0.1345 8 1.528 70.4
143  2.404 0.2025 0.1497 16.06 3.252 73.9
0
Anaemia
 0.1511 0.0845   55.9
30 0.479 0.1531 0.1029 4.66 0.713 67.2
55 0.777 0.1538 0.1049 7.41 1.139 68.2
118  1.911 0.1623 0.1216 15.72 2.551 74.9
0 Normal  0.1903 0.0945   49.730 0.49 0.1903 0.1264 3.88 0.738 66.4
0 Anaemia  0.1507 0.0839   55.730 0.48 0.1513 0.1018 4.72 0.713 67.3
0 Hypoxia  0.1624 0.0832   51.230 0.58 0.1507 0.0999 5.81 0.875 66.3
0 An&Hypox  0.131 0.0706   53.930 0.53 0.1147 0.0831 6.38 0.732 72.4
The illustrated results confirm tissue conservation of the preferred 
rate of oxygen extraction (E% 2/3rds for skeletal muscle) in the 
face of lowered arterial oxygen content at least for modest exercise 
(30 watts) and values close to this for higher work rates. So these 
relationships for exercising muscle blood flow and oxygen delivery 
convincingly demonstrate the primary role of this tissue in its own 
blood flow determination. The accuracy of the DO2:VO2 matching 
is consistent with the point made by Lane [1] that an excess of DO2 
endangers cellular biochemistry since it functions as dangerous 
free radical either itself or causes release of free radicals. The idea 
that too little arrival of oxygen is dangerous is common knowledge, 
as it is known to give rise to ischaemia with adverse consequences. 
Precision matching of delivery to usage therefore prevents severe 
consequences. 
2.4.1. Comment
The persistent, constant, DO2:VO2 ratio (1.5 +/- 0.01 sd) also 
represents a constant rate of oxygen extraction (here 2/3rds) for 
sub maximal exercise. At exercise intensities above the anaero-
bic threshold there is increased oxygen extraction, as shown for 
maximal exercise in the left hand panel of Figure 4. For maximal 
exercise DO2 then falls short of keeping pace with VO2 with the 
associated ischaemia and excess lactate release.
Figure 4: In the left hand panel we see there is successive reduction in CaO2 from normal (around 19 ml/100ml) down to the very low level (around 11.5 ml/100ml) where 
anaemia and hypoxia are combined. Oxygen extraction (E%) at that lowest CaO2 is increased above the near constant levels for submaximal exercise (blue points). For 
maximal exercise E% is increased (triangles). The E% values  for rest (maroon) are well below those for submaximal exercise, presumably reflecting mainly the E% value 
for bone. In the middle panel, E% versus work rate, the six values for 30 watt exercise show the same value – they are plotted in an array around 30 watts at 1 unit apart 
to show the individual points. For half maximum values E% is slightly raised as is the point for the lowest CaO2, ‘o’ point. In the right hand panel the inverse of oxygen 
extraction – DO2m/VO2m – is shown for 30 watts exercise, plotted against CaO2. This illustrates the constancy of the muscle DO2:VO2 balance. Mean DO2/VO2  for muscle 
is 1.50 (+/- 0.01 sd)
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Skeletal muscle is one of three major organs considered here 
which show constancy of oxygen extraction. The other two – car-
diac muscle and brain – have different, chosen, constant oxygen 
extraction values – heart 62.3% and brain 33.3%. For the kidney, 
oxygen extraction is also constant with changing VO2 where CaO2 
is normal, but DO2 is unchanged in hypoxia and anaemia, where 
the consequent reduction in venous oxygenation stimulates eryth-
ropoietin production.
2.5. Oxygen extraction for Cardiac Muscle is Normally Sus-
tained With Both Hypoxia and Changes in Metabolic Rate
For cardiac muscle oxygen extraction is constant and runs at a little 
over 60% (Figure 5) corresponding with a DO2:VO2 ratio of 1.6 
[12]. The data in the figure were calculated from the results of the 
experimental work of Martinez et al [13]. The experiment consist-
ed of hypoxic challenges in instrumented conscious dogs 10 days 
after instrumentation. The upper left hand panel of the figure shows 
blood flows with for different ranges of CaO2: normal and with 3 
progressively lower values (from lowered inspiratory oxygen). VO2 
and DO2 shown against CaO2 are shown in the upper right hand 
panel, calculated from given CaO2 and CvO2. When oxygen ex-
traction (E%) is calculated for each level of CaO2 it is within 0.05% 
of the mean (62.30) for the upper 3 levels of CaO2; only the lowest 
CaO2 gives a small but significantly higher E% value, just over 64%.
Figure 5: Right ventricular oxygenation under normal and hypoxic conditions in 
instrumented conscious dogs. The data came from Martinez et al (13) where arterial 
and right coronary artery venous blood were sampled and right coronary artery 
blood flow measured. The upper two and left lower panels (A, B and C) show plots 
of measurements and derivations from the normal data, while the lower right hand 
plot (D) shows, oxygen extraction, above, with NO blocked, open rectangles (□). 
The original unblocked plot is included, below, for comparison (closed circles). For 
interpretation see text. After Wolff (12). No permission required (Elsevier corre-
spondence)
The increase in blood flow accompanying lowered CaO2 was partly 
a result of cardiac hypoxia but also resulted from increased work of 
the heart. Cardiac work was increased as a result of increased blood 
flow to the other tissues, sustaining their normal DO2.
Hence, despite the combination of hypoxia and increased cardiac 
work rate cardiac oxygen extraction remained remarkably constant 
lower left panel of Figure 5 except for the most severe hypoxia. 
This illustrates the exquisite cardiac tissue control of oxygen deliv-
ery. Oxygen extraction lost its constancy when NO synthesis was 
blocked with nitroarginine (L-NNA panel D). Precise maintenance 
of oxygen extraction again, illustrates the tissue control of blood 
flow such that DO2 is sustained at the correct value for a specific 
tissue.
Arterial blood flow and oxygen consumption were given in this 
study. It is of interest that calculation of oxygen extraction from 
CaO2 and CvO2 enables its independent enumeration. This is use-
ful where there are difficulties in ensuring accuracy in the mea-
surement of blood flow and oxygen consumption, since the correct 
value for oxygen extraction is still available. The third major tissue 
to be considered here is the brain, with constancy of oxygen ex-
traction illustrated during exposure to the hypoxia of moderately 
high altitude.
2.6. Maintenance of Cerebral Oxygen Delivery With Sustained 
Hypoxia at Moderately High Altitude (3810 M, 12500 Feet)
Six human subjects in the classic study of Severinghaus et al [14]. 
Provided cerebral blood flow and arterial oxygen data at sea level 
and following ascent to 3810 m (12,500 feet). The subjects arrived 
from sea level after around 8 hours ascent then stayed either for 3 
or for 5 days. Again, the evidence here shows that cerebral oxygen 
delivery, at least for this modest altitude, is sustained at the sea level 
value during acclimatization to the hypoxia of altitude, despite the 
considerable changes in CaO2.
Values derived from the paper of Severinghaus et al: [14] were ana-
lyzed to give the mean changes in arterial oxygen saturation (SaO2) 
and Cerebral Blood Flow (CBF) shown in Figure 6 [12]. The mean 
values of Cerebral Blood Flow (CBF) are also shown (on the right). 
It is apparent that the CBF values have an inverse pattern compati-
ble with constant cerebral oxygen delivery.
Constancy of cerebral DO2 is confirmed in the face of hypoxic 
change, as illustrated in Figure 7. Values of DO2 are shown coded 
separately for individuals on the left. On the right of the figure all 
points are plotted uncoded to enable regression analysis. Regres-
sion shows no significant trend. Only data from five subjects was 
analyzed as there was no Hb value for one of the six.
The constant DO2, at the normal sea level value during acclimati-
zation, illustrates the maintenance of a constant DO2 to VO2 ratio 
in the face of changes in CaO2 over five days at altitude. Mean ce-
rebral oxygen extraction here is 34% so that, close to 3 ml DO2 are 
delivered per ml VO2.
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Figure 6: This shows that, on average, there is a near 20% fall in SaO2 at 8 hrs (from 
96% to 79%) then (steady recovery to 88% at 3 days and 90% at 5 days. The opposite 
changes in CBF, shown on the right, show an initial rise to over 25% above the sea 
level value, then gradual decline over 5 days to around 13% above the sea level value. 
(12) Here we have considered average values, which come from an earlier analysis 
(12) of data from Severinghaus et al. (14) Figure 7 shows individual DO2 values.
Figure 7: Cerebral DO2 at sea level, at around 8 hours, 3 days and five days at 3810 m 
(12,500 feet) for individual subjects. On the left values are plotted shown with differ-
ent symbols for individual subjects. On the right a regression line is fitted through 
the values for all five subjects. It is clear that DO2 was sustained, with maintenance 
of the sea level value during the five days acclimatization despite changing arterial 
oxygenation. 
The evolution of cerebral oxygen utilization is well described in a 
review by Bailey [15]. The review stresses the importance of sus-
taining the constant ratio of oxygen delivery to oxygen consump-
tion for the brain. As mentioned, both excess and insufficient DO2 
give rise to excess free radicals – Reactive Oxygen Species (ROS). 
This reinforces the importance of the specific control of individual 
tissue blood flow such that DO2 is sustained at the appropriate ra-
tio to VO2. This, of course, amounts to sustaining constant oxygen 
extraction.
This third major tissue confirms the exceedingly accurate control 
by individual tissues of blood flow to sustain the individual tissue 
appropriate DO2 relative to its rate of oxygen consumption. This 
confirms the fact that blood flow in the circulation is regulated at 
each individual tissue. It is apparent that control from neither heart 
or brain could render these precision rates of oxygen flux to indi-
vidual tissues.
2.7. DO2 for Splanchnic and Renal Circulations
Splanchnic auto-regulation, sub serving metabolic rate changes 
is seen following meals, where secretion, absorption and smooth 
muscle contraction are accompanied by increased blood flow ac-
companying the increases in local VO2.
Renal blood flow priority also sub-serves DO2 requirements but, 
in the face of lowered CaO2 (hypoxic or anaemic), blood flow is 
unchanged, resulting in renal ischaemia [16]. At altitude this is 
illustrated in (Figure 8) by the increased renal oxygen extraction 
at 2400 m (7874 feet), whereas oxygen extraction is constant for 
muscle, liver and brain for this altitude. Renal ischaemia stimulates 
erythropoietin production sub-serving the oxygenation interests 
of the body as a whole. Note the lowered oxygen extraction at the 
highest altitude (5050 m, 16570 feet).
Figure 8: Oxygen extraction is plotted against height (left) and SaO2 (right). (16) 
The original expedition data are from Beasley et al [17]. Figure re-plotted from orig-
inal data
2.8. Summary of Section 1
Evolution has enabled exquisitely accurate adjustment of organ, 
and within organ, input resistance such that there is an appropriate 
rate of oxygen arrival in the arterial blood. The reasons for the dif-
fering tissue specific values for oxygen extraction (or for DO2:VO2 
ratio) is unknown, but the precision is extraordinary. Accepting 
this feature of circulatory control is important, simplifying many 
circulatory control features and avoiding assessment errors. Tis-
sue regulation of blood flow means that blood pressure is not con-
trolled by the relationship between flow, resistance and pressure. 
Control of arteriolar resistance for individual organs is dominated 
by tissue adjustment. Although there is sympathetic nervous in-
nervation of arterioles, tissue adjustment via alteration of arteriolar 
resistance is managed around the ongoing Mean Arterial Pressure 
(MAP), commonly referred to as auto-regulation. This means there 
must be constant levels of arteriolar sympathetic activity to avoid 
interference in the accuracy of DO2:VO2 tissue matching. It also 
means that control of arterial blood pressure cannot be via alter-
ations in arteriolar resistance, especially in view of the fact that sys-
temic vascular resistance is the combined effect of the accumulat-
ed values for all tissues. In order to resolve the problem of arterial 
pressure control, independent of arteriolar resistance adjustment, 
the second section shows that arterial blood pressure is determined 
by the total blood volume and its distribution between arterial and 
venous compartments.  
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Once accepted that tissues normally determine their own con-
stancy of oxygen extraction the phenomenon requires research to 
find out the mechanism of such precise adjustment. This should 
be greatly facilitated by the discovery of the “pathway that directly 
signals oxygen levels in cells, and its major components”, described 
in a recent paper [18].
SECTION 2
3. Mechanical Features of the Circulation Which Under-
pin Arterial Blood Pressure and its Changes
3.1. Introduction
This section explains why the current idea that arterial blood pres-
sure and its changes depend on systemic vascular resistance and its 
changes, requires radical revision. Also, that this revision explains 
paradoxes inherent in the current accounts of arterial blood pres-
sure regulation.
Guyton et al [7], studying circulatory control, recognized the pri-
mary role of tissues in blood flow control and pointed out that “it 
is often thought that nervous control of arterial pressure is effected 
almost entirely by changing the resistance to blood flow through 
the small tissue blood vessels. However, an increase in resistance 
would decrease blood flow through the tissues. Therefore, when a 
tissue demands additional quantities of blood flow because of its 
local needs, vasoconstriction of its arterioles to maintain the arte-
rial pressure would be very detrimental to the tissue’s own needs.” 
They then say “Fortunately, the local vasodilating effect caused by 
increased metabolism usually prevails over the vasoconstricting 
effect of the nervous signals, and the net result is decreased vascu-
lar resistance rather than increased resistance.” There is therefore 
a problem, as to how arterial pressure can be adjusted dynamical-
ly without resort to arteriolar resistance control and with blood 
flow determination primarily residing at tissue level. Although a 
solution was offered it was not dynamic, nor did it overcome the 
fundamental problem faced by attempting an explanation simply 
based on the Ohms law like relationship between cardiac output, 
systemic vascular resistance and mean arterial pressure difference 
from venous pressure. And the problem has been with us ever 
since. Section 1 confirms that the primary blood flow and DO2 reg-
ulatory action occurs at arterioles, led by the tissues. As explained, 
changes in metabolic rate (as evidenced by oxygen consumption, 
VO2) of individual organs are accompanied by precise changes in 
blood flow, such that DO2 is increased or decreased in the same 
proportion as VO2. For exercise there is an upper limit above which 
oxygen extraction is increased. In the usual range of metabolic rate 
(less than heavy exercise) the blood flow adjustments sustain the 
particular organ’s preferred DO2 to VO2 ratio (or its inverse – ox-
ygen extraction). This preferred ratio (or, the inverse, oxygen ex-
traction) is also sustained where arterial pressure changes and, 
where arterial oxygen content changes, so long  as the changes are 
not too great. When arterial pressure changes, without a change in 
VO2, each local organ’s arteriolar resistance changes in proportion 
to the pressure change – the well-known phenomenon of auto-reg-
ulation. Again, this is tissue mediated, with the resistance change 
therefore being a consequence of the pressure change via tissue 
action. There must therefore be a reason for a change in pressure 
which is not dependent on SVR change, since that is already deter-
mined as the integration of the actions of multiple tissues. The new 
model shows there can be arterial pressure change independently 
of sympathetic stimulation of arteriolar resistance. The changes in 
arterial blood pressure are specifically due to changes in arterial 
volume. This is enlarged upon later in this section.
It is important to realize that changes in blood flow can be a result 
of changes in peripheral resistance, especially at arteriolar level. 
When arterial pressure does not change, despite changes in VO2, 
say for example in mild-moderate exercise in normal subjects [19], 
the extra DO2 is delivered entirely as a result of an increase in blood 
flow to the tissues, and this is due to tissue mediated reduction of 
SVR (mainly the resistance fall of the exercising muscle). By analo-
gy, the variable flow of air supplying the pipes during performance 
in an ancient hydraulic organ, was sustained by a wind-chest kept 
at constant pressure by a water chamber. The Hydraulis was de-
signed by Ctesibius of Alexandria (circa. 300 BC), the earliest de-
scription of any wind powered device [20]. This illustrates that 
blood-flow regulation by the tissues does not require a change in 
the mean arterial pressure; it may, and often does, result simply 
from adjustment of resistance.
The argument, concerning arterial blood volume, in the present 
section is offered as the solution to the problem of arterial pressure 
control independent of SVR and blood flow.
Since Guyton et al [7] put forward the problem subsequent authors 
have made conflicting assertions despite making or quoting many 
useful measurements. As a representative example of the problems 
involved in the interpretation of good data, a review of Safar and 
London [21] contains a multitude of examples. They assume for 
example ‘a role of capacitance vessels on the regulation of cardiac 
output’; ‘filling pressure of the heart is of paramount importance 
for the understanding of normal cardiac output…..’; ‘…increase 
in central venous pressure in hypertension ……accounted for by 
a decrease in right ventricular performance’; ‘changes in cardiac 
output induced by volume expansion’; ‘the contribution of vascular 
capacitance to the control of cardiac output’; and ‘the only possibil-
ity of maintaining a normal CO in essential hypertension is to have 
an increased MCFP’ (Mean Circulatory Filling Pressure); ‘control 
of mean circulatory pressure and filling pressure of the heart so as 
to ensure adequacy of the circulation especially of the cardiac out-
put.’ All these statements conflict with the correct comment, made 
at the end of their review, ‘Unlike the resistance vessels, which al-
ter their calibre in response to metabolic changes, the capacitance 
vessels are regulated through sympathetic nerve stimulation.’ Many 
measurements quoted in the paper support the hypothesis put for-
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ward in the present paper. Here we point out that pressure change 
involves arterial volume change due to venous volume change in 
the opposite direction.
More recently, Guyenet’s article on the sympathetic control of ar-
terial blood pressure [22], while giving comprehensive informa-
tion about cerebral connections and baro-reflex phenomena, gives 
statements which, again conflict with the idea that arteriolar resis-
tance is controlled by tissues in relation to metabolism, also com-
pensating for pressure change (auto-regulation) and for changes in 
arterial oxygen content (CaO2). For example ‘…neural control of 
the circulation is primarily designed to regulate blood volume and 
blood flow (cardiac output and its apportionment) at the expense 
of BP’. Also, ‘BP is a function of vascular resistance and cardiac out-
put……two variables that are controlled by the autonomic nervous 
system.’ ‘cardiac output is controlled by three variables: end-dia-
stolic volume, myocardial contractility and heart rate.’ Again, these 
are not compatible with tissue control of blood flow and DO2.
In a lecture given by Fink [23] consideration given to venous ca-
pacitance and compliance is supportive of the present hypothe-
sis. However, to quote: ‘The hallmark hemodynamic change in 
established hypertension clearly is increased vascular resistance’. 
This has been taken to mean that the raised pressure results from 
a sympathetically mediated increase in arteriolar resistance. This, 
again conflicts with the dominant role of the tissues in the control 
of blood flow. Once we realise that tissue resistance follows chang-
es in metabolic rate, pressure and CaO2, it becomes a truism that 
SVR change is normally secondary to pressure regulation, not the 
primary driver – correlate not cause.
There are very many articles with interpretations of data, attempt-
ing to explain arterial pressure regulation which conflict with the 
tissue control of blood flow and DO2. We will show that while the 
tissues independently control blood flow, under normal circum-
stances, the simple means by which arterial pressure is adjusted 
also acts independently. Published data is entirely compatible with 
the mechanism proposed here for independent arterial pressure 
control. Regulation of arterial pressure is volume based and de-
pends on total blood volume and the venous to arterial distribu-
tion which is largely determined by sympathetically driven venous 
tone. Once understood the new insight opens the flood gates for 
research likely to improve understanding of both normal and dis-
ordered circulatory physiology. The following section considers the 
proposed underlying mechanisms in some detail.
3.2. Argument
Blood vessel compliances determine the ways in which the internal 
pressures are related to the contained volumes. With different com-
pliance values in arteries and veins the total blood volume is parti-
tioned with a much larger venous than arterial volume. This is true 
in life at mean systemic pressure and even after death at zero pres-
sure. In life the heart continuously pumps blood into the arterial 
side of the circulation and, facing arteriolar (peripheral) resistance, 
generates a pressure according to the resulting arterial volume. On 
reaching the venous system, the volume is much larger [24] and 
compliance much higher and adjustable. Venous compliance ad-
justment occurs particularly from sympathetic activity acting on 
venous wall musculature. Venous blood flow continues to the heart 
with a much lower driving pressure. Normally, this ‘venous return’ 
becomes the output into the arterial system. This cardiac pump-
ing action then sustains the arterial volume and hence the arterial 
blood pressure.
The equilibrium state, between arteries and veins, depends both on 
total blood volume and the arterial and venous compliance proper-
ties. Venous wall tone is effectively the inverse of compliance (dp/
dv rather than dv/dp). An increase in venous wall tone will mean 
there is a new compliance ratio between veins and arteries – a re-
duction in vein: artery compliance ratio, or increase in venous to 
arterial tone. Where the change is an increase in venous wall tone it 
will result in a new volume equilibrium, with a reduction in venous 
and an increase in arterial volume. The increased arterial volume 
means there is an increase in arterial pressure. This occurs simply 
while circulation continues such that CO is unaffected – there is a 
volume shift between compartments (venous and arterial) rather 
than an increase in blood flow. The reverse, a reduction in venous 
wall tone will displace a volume from the arterial to the venous 
compartment; the basis for a reduction in arterial pressure (be-
cause of the reduction in arterial volume). This concept of a vol-
ume displacement, without any change in blood flow, is unfamiliar 
to most people but is an essential feature of the regulatory process.
A reminder, although arterial blood pressure, at a given fixed value 
of SVR will depend on the force of contraction of the heart, pre-
cise control by individual tissue components of the peripheral re-
sistance normally determine the specific blood flow appropriate to 
the metabolic rate of each tissue (section 1). Any change in Mean 
Arterial Pressure (MAP) will have been caused by a change in ve-
nous volume in the opposite direction. Each tissue will normally 
respond to such a pressure change with a proportional change in 
resistance, such that blood flow remains at the appropriate level 
- the basis of auto- regulation of blood flow [25]. The total of all 
the individual tissue blood flows provides the venous return, which 
then becomes cardiac output. Hence, cardiac output is controlled 
by the tissues and resides at all the individual tissues, despite the 
fact that the energy required to maintain blood flow and hydro-
static pressure is provided by cardiac action. It is therefore the com-
bined action of the tissues rather than the heart which determine 
cardiac output. To return to arterial blood pressure, in particular 
the mean value (MAP), it is apparent that the total blood volume is 
one important determinant, while the second is the volume distri-
bution ratio between arteries and veins. Since, the distribution de-
pends largely on venous tone the precise value of arterial pressure 
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at any one time depends both on blood volume and venous tone, 
mainly adjustable by sympathetic innervation (specifically on the 
venous side of the circulation). The volume relationships determin-
ing arterial pressure and its variations mean they are independent 
of the control of blood flow. To repeat, arterial pressure is normally 
independent of arterial blood flow. With blood flow adjusted by the 
tissues, sustaining a precise DO2 to VO2 ratio, changes in MAP are 
usually accompanied by parallel, tissue induced, changes in arteri-
olar resistance for the majority of body tissues. This has meant that 
experiments where venous tone is increased are accompanied by 
increased SVR, which, to date, has been assumed to be mediated by 
the same agent. However, the increase in SVR will normally be tis-
sue mediated, compensating for the increased arterial blood pres-
sure, thereby sustaining the original blood flow (auto-regulation). 
Hence, there is no role, under most normal circumstances, for a 
change in the activity of the sympathetic innervation of arterioles.
The radical change in emphasis in arterial pressure control from ar-
teriolar resistance to venous tone (and total blood volume) means 
that there is no longer an expectation that there will be arteriolar 
sympathetic involvement in arterial pressure regulation. The ba-
sic blood pressure control mechanism is therefore fundamentally 
different from current thinking. Arteriolar sympathetic innerva-
tion may well be present to cater for emergency situations. It seems 
likely that there is normally a ‘tonic’ level of arteriolar sympathetic 
activity – a subject worthy of further investigation.
Considerations of cerebral blood flow and auto-regulation help to 
illustrate the factors involved. Tests of auto-regulation have utilized 
induced increases in arterial pressure, which we can now attribute 
to changes in venous wall tone. Cerebral blood flow is unchanged 
over a wide range of arterial pressure, only rising with excessive 
pressure or falling with extremely low pressure. When the cere-
bral sympathetic supply is removed there is no change in the range 
where cerebral blood flow remains unchanged. However, when 
some extra sympathetic stimulation is added, there is an extension 
to a higher pressure level before the rise in blood flow occurs. So, 
for cerebral auto-regulation no sympathetic activity changes are 
involved normally. Furthermore, “Neither surgical division nor 
electrical stimulation of the cervical sympathetic nerves influenc-
es cerebral blood flow under normal conditions” [26]. There is an 
important role, however, for the sympathetic innervation of arte-
rioles, which has been documented for cerebral vessels. Where a 
sudden extreme rise in pressure occurs it will be met by (arteriolar) 
vaso-spasm mediated by the sympathetic, protecting cerebral tis-
sue from damage.
An example of auto-regulation, applicable to the whole body, is the 
tissue adjustment of blood flow, which sustains normal resting car-
diac output in patients with established hypertension, despite the 
raised Mean Arterial Pressure (MAP) [27]. Since this is the basis 
of auto-regulation it is clear that the Systemic Vascular Resistance 
(SVR) must have changed as a result of tissue action. It may be 
that auto-regulation has been recognized for individual organs but 
has not been recognized as being near universal and therefore ap-
plicable to SVR and sustained cardiac output. It is therefore the 
response of the majority of tissues to raised pressure which leads to 
raised SVR – contrary to current thinking.
The kidney also exhibits auto-regulation of blood flow in relation 
to arterial pressure changes and modifies blood flow in relation to 
changes in metabolic rate [28]. However, unlike other tissues, renal 
blood flow does not respond to reduction in the amount of oxygen 
carried in the arterial blood supply – (arterial oxygen content - 
CaO2). When arterial oxygen content is lowered, either from anae-
mia or low arterial oxygen saturation (SaO2) there is no change in 
renal blood flow. This results in tissue ischaemia stimulating eryth-
ropoietin production.
Since, the result of existent venous tone will also depend on total 
blood volume there is room for differing pairs of values – venous 
tone and blood volume – for a given arterial pressure. The venous 
tone and its changes act well for rapid arterial pressure change 
though the sustained value of venous tone will also be relevant 
for longer term pressures. Normally, total blood volume changes 
are necessarily longer term. Furthermore, the venous tone, while 
under rapid dynamic control via the sympathetic innervation, is 
under influences from endocrine factors affecting endothelial re-
ceptors. Examples are catecholamines, angiotensin 2 and endothe-
lin 1 [29]. Conversely venoconstriction by both Endothelin-1 and 
the Endothelin-B receptor agonist S6c are markedly attenuated by 
endothelial ET-B mediated production of vasodilator substances 
prostacyclin and NO [29, 30]
It is a simple fact of physics that there can be no change in arte-
rial pressure without a change in arterial volume [31, 32]. There 
is a simple saturating exponential relationship between function-
al arterial volume and pressure, approximating: V = 250(1 – e(-
0.0092P)) which is shown on the left of Figure 9. The data describ-
ing the relationship originated in the work of Remington et al [31] 
and is part of an algorithm, utilized commercially (PulseCO, LiD-
CO, PLC, UK) to derive stroke volume from arterial blood pressure 
[33]. The inverse equation: P = -108.7 x ln(1 – V/250), giving the 
plot on the right of Figure 9, has been used in a model to derive pu-
tative arterial pressure waveforms from imposed stroke volumes. 
The commercial algorithm then returns values close to the original 
stroke volumes [32]. This direct relationship (arterial pressure ver-
sus arterial volume) shows how movement of a volume of blood 
into or out of the arterial system will change the pressure. It also 
illustrates the great increase in arterial wall stiffness seen at the 
higher pressures, when the high pressure and reduced compliance 
oppose further volume input.
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Figure 9: Arterial pressure and volume. On the left functional arterial volume V, 
derived from arterial pressure P, is V = 250(1 – e(-0.0092P)); while on the right 
pressure is derived from the inverse equation, P = -108.7 x ln(1 – V/250). On the 
left we see arterial compartment volumes, above relaxation volume, corresponding 
to arterial pressures. On the right we see the arterial pressures resulting from those 
volumes. The exponential, derived by Wolff from lookup tables utilized by Band et 
al (33) in an early commercial monitor, fitted the original data of Remington et al.
3.2.1. A Second Reminder of The Basis of Arterial Pressure and 
its Changes. 
Changes in arterial volume, and hence changes in arterial pressure, 
can only come from exchange of a volume of blood to or from 
the rest of the circulation, in particular the systemic venous com-
partment. Changes in mean arterial pressure result from changes 
in venous tone mediated by venous smooth muscle sympathetic 
innervation. This transfers blood from one compartment to the 
other. Since the arterial pressures are mathematically related to the 
arterial volume there can only be arterial pressure changes where 
venous volume changes occur (in the opposite direction).
Although venous tone has been measured in a variety of situations 
[34, 35] its specific relationship to arterial pressure requires formal 
study. Theoretically, there will be minimum venous tone (maxi-
mum compliance) when arterial pressure is zero (at relaxation vol-
ume). Higher venous tone values will underpin the redistribution 
from veins to arteries required to sustain normal arterial pressures. 
Certainly Sharpey-Schafer [34, 35] demonstrated increased venous 
tone and arterial pressure following catecholamine administration. 
This means that rapid arterial pressure change must have meant 
similarly rapid changes in venous volume. Longer term adjustment 
of total blood volume on the basis of ‘pressure-natriuresis’ may, 
hypothetically, restore normal pressure in the face of persisting 
venous tone change; this, because it results in blood volume ad-
justment. Total blood volume in hypertension is either normal or 
reduced and there is an associated reduction in the effectiveness 
of pressure natriuresis [36]. When sympathetic nervous innerva-
tion of the venous wall musculature changes, for example when 
it reduces venous wall compliance (increases venous tone), there 
will be a small increase in venous return to the heart. The heart 
puts out what it receives, imparting the required energy to pass on 
any increased return as output. However, this volume increment 
is retained in the arterial compartment by the extra total system-
ic pressure thereby increasing arterial volume and hence pressure. 
The sympathetic innervation responsible for pressure change is the 
venous sympathetic supply; [37] modulated, more slowly, by endo-
thelial mediators such as Endothelin-1 [29].
The relative volumes of arteries, capillaries and veins are illustrated 
in (Figure 10).
Figure10: The arterial and venous volumes differ in a ratio of approxi-
mately 1:5. The diagram gives typically quoted values of compartment 
percentages of the total volume. Venous compliance is far  greater than 
arterial, often quoted as 30 to 1. But venous compliance varies with venous 
sympathetic  activity because of the resulting changes in venous wall ten-
sion (or venous tone – the inverse of  compliance).
The question arises as to the extent to which short term arterial 
pressure changes depend on venous tone/compliance changes. 
Changes in the compliance or stiffness of arteries, in an individual, 
at least in the short term (as distinct from veins) is thought to be 
principally dependent on existing Mean Arterial Pressure (MAP) 
and the structural properties of the arterial walls. There is thought 
to be little if any dynamic effect of the sympathetic nervous sys-
tem on individual “arterial stiffness; it is otherwise independent of 
sympathetic nervous activity” [38]. Hence, arterial pressures are 
intimately dependant on the state of venous compliance/tone. If 
we are to account for the sympathetic innervation of arterioles the 
tissue control will be operating normally only if the effect of arteri-
olar sympathetic activity is constant. If MAP increases without any 
change in resistance CO will increase in proportion to the MAP 
increase. With stress induced increases in arterial pressure there 
may be similar increases in SVR preventing the increase in CO. 
This is the classic mechanism of auto-regulation.
We have reached the point where it is apparent that there are sepa-
rate causes of blood pressure (total blood volume and venous wall 
tone) and blood flow (tissue action on arteriolar resistance). The 
physical causes of blood flow include the upstream pressure and 
the local arteriolar resistance which is largely regulated by the tis-
sues. It is therefore likely that pressure control includes keeping the 
sympathetic influence on arteriolar resistance constant, thereby 
enabling tissue regulation to exert changes which specifically serve 
DO2 regulation. 
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We see from this argument that:
1. Arterial pressure depends on total blood volume and venous 
tone.
2. Arterial pressure changes result from venous volume changes 
mainly mediated in the short term by the venous sympathetic sup-
ply.
3. Changes in arteriolar resistance are mainly mediated by tissue 
responses to metabolic rate change, alterations in MAP and in ar-
terial oxygen content. All changes act to sustain appropriate DO2.
4. The sympathetic supply to arterioles normally remains steady in 
the face of the precise tissue auto-regulatory action on arterioles.
5. Small changes in venous tone and volume generate large changes 
in arterial pressure since the small new volume enters a volume 
(arterial) much smaller than venous. The necessary energy to sus-
tain arterial pressure comes from cardiac action.
6. Control of blood flow is a distributed function involving the re-
sponses of individual tissues, whereas arterial pressure control is 
universal and mediated by reflexes and regulation of blood volume 
and its distribution.
7. The realisation that short term arterial blood pressure control 
involves venous volume change, and that this combines with total 
blood volume in the longer term, means that blood pressure con-
trol is, for the most part, independent of blood flow control (see 
later). A schematic (Figure 11) illustrates the short and long term 
mechanistic basis for arterial blood pressure regulation.
Figure 11: Volume relationships to arterial pressure. On the left the smoothed rect-
angles represent venous volume, the thin ovals the arterial volume. The upper pair 
represents larger venous and smaller arterial volume meaning a lower arterial pres-
sure. Below there has been loss of a small venous volume (small circle) and transfer 
to the arterial compartment which is now larger. The larger arterial volume will 
mean a higher arterial pressure. On the right the total volume is representative of 
systemic venous and arterial volumes together. Now the alteration of volume is to or 
from the exterior. The larger total volume (lower area) will mean higher pressure so 
long as the relative arterial/venous balance is appropriate (around 1 to 5).
3.3. Supportive Evidence
Studies of the behavior of the venous system require measurement 
of its volume, pressure and the compliance or tone of its walls. An 
additional measurement is the Mean Systemic Filling Pressure 
(MSFP), obtained by pressure measurement after equilibration fol-
lowing cessation of cardiac action. “It is an indicator of how full 
the circulatory system is (i.e. the volume of blood in the system 
compared to the capacity of the system), and is influenced by the 
volume of circulating blood and the smooth muscle tone in the 
walls of the venous system” [39]. The various approaches to mea-
surement of venous volume and pressure are outlined in detail in 
a large review [40] in which measurement results are also quot-
ed. The results given include changes of arterial pressure and SVR 
in the same direction, and this has been interpreted as action of 
the sympathetic on both veins and arterioles. To date it has been 
assumed that the correlation between MAP and SVR meant that 
SVR changes caused MAP changes. However, as explained, MAP 
changes come about from venous tone changes. As explained ear-
lier, the correlation with SVR comes about from compensatory tis-
sue adjustment of SVR preventing blood flow change. Hence, cau-
sality is in the opposite direction – blood pressure change results in 
SVR change rather than the other way round – a complete reversal 
of current thinking.
3.3.1. Studies Concerning the Venous System in the Review of 
Catherine Pang
This large review [40] examines the physical basis of venous com-
pliance (or its functional inverse – tone). Methods of measurement 
are outlined first, then aspects of the sympathetic nervous system, 
the baroreceptor reflex and drugs with autonomic related effects. 
Venous function in disease is also considered. Measurements made 
with the various techniques confirm the major role of sympathet-
ic activity. Increased sympathetic activity is shown repeatedly to 
be accompanied by increased MAP and SVR. Again, it is assumed 
that this means the increased SVR is driven by the increased sym-
pathetic activity or sympathomimetic drugs. The accompanying 
increased venous tone is found to cause reduction in venous vol-
ume and increased venous pressure. Also, there is the assertion that 
these increases in venous tone drive some blood from the venous 
side of the circulation to the arteries but the assumption is then 
made that this is generating increased blood flow. The phenomena 
quoted and measurements made are compatible with transfer of 
venous blood into the arterial system, as a result of venous volume 
reduction. However, the transfer is only between compartments, 
not a change in blood flow.
The interpretation in the review, is that the increase in SVR is sym-
pathetic driven and is the cause of the rise in pressure; this ignores 
the fact that the studies have shown reduction in venous volume 
which is necessarily the basis of the increase in arterial volume and 
hence the increase in arterial pressure. This means there must be a 
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reason, after the event, for the increase in SVR. As described above 
there are strong reasons for concluding that it is the tissue response, 
preventing the increase in pressure from an inappropriate increase 
in blood flow – the basis for the increase in SVR.
Examples From The Paper: Including Baro-Receptor Function 
And Cerebral  Vascular Reactivity.
Quotes from Pang [40]
1.…stimulation of the carotid sinus nerve reduced arterial pres-
sure, peripheral vascular resistance…
2….infusion of adrenaline (1.2 μg/kg/min) increased arterial pres-
sure and resistance concurrently…
As a result the author concludes there is sympathetic drive to both 
veins and arterioles: “These studies show that the carotid sinus 
baroreflex system regulates systemic resistance and capacitance 
vessels in the same direction…”.
These results are consistent with the new theory, but most of the 
experimental work quoted fails to leave tissue regulation in place, 
because of experimentally keeping cardiac output or limb blood 
flow constant.
3. For example Deschamps and Magder [41] investigated whether 
splanchnic venous volume reduction induced by carotid sinus hy-
potension (to 50 mm Hg) in dogs was due to sympathetic activa-
tion. To accomplish this, phentolamine (an α-adrenoceptor antag-
onist, 0.2 mg/kg) was given with a resultant increase in splanchnic 
volume (5.4 + 3.7 sd ml/kg). Further confirmation with the addi-
tion of hexamethonium (a ganglionic blocker, 5 mg/kg) increased 
splanchnic volume further (to 10.2 + 2.5 ml/kg). However, their 
experiment involved diversion of superior and upper and lower in-
ferior vena-caval blood to a reservoir. From there blood was taken 
to give a pre-determined venous return and hence a fixed cardiac 
output. The arteriolar resistance control by the tissues was thereby 
bypassed.
4. Several further experimental results with carotid sinus stimula-
tion or inhibition are given, all utilising artificially fixed levels of 
cardiac output. Low carotid sinus pressure reflexly raised systemic 
arterial pressure and high carotid sinus pressure lowered systemic 
pressure. The SVR values, obtained went in the same direction as 
arterial pressure. The same problem, as in the paper of Deschamps 
and Magder [41] was that the fixing of cardiac output (CO) pre-
vented tissue control of blood flow. 
The fact that the SVR changes parallel the arterial pressure changes 
does not mean that it is reasonable to attribute the SVR changes to 
the arteriolar sympathetic innervation for two reasons:
1. The experimental work quoted in 3, and 4, above prevented nor-
mal tissue effects on arteriolar resistance, and 
2. The calculated SVR values depended on seeing a rise in pressure 
while forcing a fixed blood flow. This would mean that the calculat-
ed resistance would change in precise proportion to the change in 
value of the mean arterial pressure and not represent the behavior 
of the arterioles. In other words the calculated SVR, under condi-
tions of fixed blood flow, is a mathematical but non-physiological 
value.
These experiments with carotid sinus pressure changes and fixed 
blood flow only demonstrate sympathetic involvement in the pres-
sure change part of the response (via venous action).
On the other hand a pharmacological example (5. below) illus-
trates pressure and SVR changes consistent with tissue compen-
sation, where there is a parallel change of pressure and SVR rather 
than sympathetic action on arterioles. 
5. “In sedated intact dogs given atropine (antimuscarinic) to con-
trol HR, a low (6 – 10 μg/kg/min) and a high (11 – 15 μg/kg/min) 
dose of methoxamine, which caused a 50% and 100% increase 
in arterial pressure and arterial resistance, respectively, dose-de-
pendently increased the MCFP, but did not alter CO” [42].
In this example CO was not fixed by the operators, the increased 
MCFP means there was increased venous pressure causing the in-
crease in arterial pressure by means of a venous to arterial volume 
shift. The tissue response could, and presumably did, operate, com-
pensating for the CO driving effect of the increased pressure, with 
resulting increased SVR (auto-regulation again). Hence, CO was 
unchanged. 
These notes on re-interpretation of the findings quoted by Pang 
include the major misinterpretation, in the paper, of the venous 
control illustrated. “The major function of the capacitance vessel is 
to regulate (maintain) venous return and, therefore, CO.” In sum-
mary, the apparent sympathetic effect on arterioles, is either from 
sustaining constancy of CO, or failing to realize the tissue role in 
the SVR changes in response to changes in arterial blood pressure. 
3.3.2. Baro-Receptor Function Before and After Two Types of 
Carotid Endarterectomy 
Demirel et al [43] have compared the two major forms of carotid 
endarterectomy, both of which include removal of atheroma. One 
(older) manoeuvre often referred to as standard carotid endarter-
ectomy (s-CEA) or conventional (C-CEA) utilizes a longitudinal 
arteriotomy at the carotid bifurcation, removal of the atheroma 
and closure of the artery occasionally with a patch. The carotid si-
nus nerve (CSN) remains intact. The second (newer) method uti-
lizes eversion of the vessel as part of the repair and includes carotid 
sinus nerve section. The acronym e-CEA or E-CEA is usually used 
to clarify that this method is used. Prior to operation many pa-
tients were hypertensive. The study compared 27 C-CEA and 37 
E-CEA patients pre- and post- operation – at 24 and 72 hours. For 
C-CEA patients carotid endarterectomy resulted in increased Ba-
ro-Receptor Sensitivity (BRS) and a reduction in arterial pressure 
(both significantly) at both 24 and 72 hours post-operatively. For 
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E-CEA carotid endarterectomy resulted in a highly significant fall 
in BRS and the arterial pressure fall was small (yet significant) at 24 
hours but there was no significant change at 72 hours. The reduced 
BRS for E-CEA was from loss of the ipsilateral sinus nerve input as 
a result of nerve section. The authors point out that “ … increases 
in carotid bulb diameter from patch angioplasty after C-CEA may 
result in increased wall tension at the same intraluminal arterial 
pressure. Under preservation of the CSN, an increased BRS after 
plaque removal results in an increase of the CSN activity, followed 
by lowered HR, and decreased blood pressure. ” That the improve-
ment in haemodynamics following C-CEA with intact carotid si-
nus nerve may last long term is supported by the study of Hirschl 
et al [44]. 
“ … Improvement in receptor sensitivity was associated with a 
5-year reduction in the absolute level and lability of blood pres-
sure.” 
Pang’s article [40] states that Angel James and colleagues demon-
strated that the manoeuvre (carotid endarterectomy) improved 
carotid baroreflex sensitivity as a result of increased arterial pul-
satility, due to improved local arterial compliance. However, the 
paper, by Angell James, [45] actually shows that for their 11 carotid 
endarterectomy patients the vessels were stiffer and that increases 
in Carotid Sinus Nerve (CSN) activity correlated with increases in 
carotid arterial diameter. “The operative procedure was found to 
change the mechanical properties of the arterial wall, there being 
an overall increase in diameter and reduction in distensibility,…..”. 
For 6 of the patients, in whom arterial pressure and CSN activity 
were both measured they obtained the result shown in (Table 3).
Table 3: Changes in CSN discharge and arterial blood pressure following 
C-CEA
Number of patients 3 2 1
CSN discharge change + - 0
Arterial pressure change - + 0
‘+’ signifies an increase; ‘-‘ signifies a decrease; ‘0’ signifies no change
These findings and earlier quoted animal studies offer unique sup-
port for the inverse relationship between baro-receptor firing rate 
in the sinus nerve and the level of arterial blood pressure. One of 
the authors of the present paper (DWG) has also noticed the high 
frequency of hypertension in patients requiring carotid endarter-
ectomy [46]. With carotid endarterectomy (the older version with 
intact sinus nerve – (s- or C-CEA) arterial pressure was normalised 
in a high proportion of patients following operation. The beneficial 
effect of this version of carotid endarterectomy is confirmed by the 
study of Vachev et al [47]. Although the paper is in Russian, the ma-
jor findings are given in the English translation of the abstract. 105 
patients had carotid endarterectomy (C-CEA). Prior to operation 
all had more than 70% stenosis of the carotid bifurcation. Ninety 
two (87.6%) had presented with resistant hypertension. 43.8% (46 
patients) were classified, prior to operation as having grade III hy-
pertension. The incidence of hypertension fell postoperatively to 
5.8% (6 patients) in the remote postoperative period. These results 
are consistent with improvement of baro-reflex sensitivity, though 
no information appeared on BRS in the abstract.
A further surprise is that the two types of endarterectomy men-
tioned above may well have been used in many studies where the 
universal finding is of loss of baro-receptor sensitivity [48]. Fur-
thermore there are those who anaesthetise the sinus nerve to pre-
vent hypertension during the operation. The realization that im-
provement in arterial pressure can be achieved from carotid arteri-
al endarterectomy, where the sinus nerve remains intact, suggests 
there could be considerable therapeutic benefit from adopting the 
particular way in which the older CEA is conducted. Careful an-
atomical studies of the variation in location of the baro-receptor 
have been published recently [49]. This could well help optimise 
CEA methodology and lead to improved arterial pressure control 
in these patients. 
3.3.3. Further Supportive Evidence 
a) The consistent finding during anaesthetic induction of a fall in 
arterial blood pressure has recently been attributed to a drug in-
duced reduction in venous tone [50, 51]. The reasoning given is 
that with induction of anesthesia an increase occurs in the vari-
ation of stroke volume and pulse pressure indicating volume re-
sponsiveness due to venous relaxation and not loss of volume. For 
this state administration of fluids improves pressure and helps to 
restore reduced blood flow. Since, there has usually been no loss 
of actual blood volume; the apparent shortage has been attribut-
ed to venous wall relaxation, so that some arterial blood has been 
transferred to the venous side of the circulation. This is supported 
by the fact that venous tone can be largely supported by the action 
of a low maintenance dose of phenylephrine introduced prior to 
and continued during induction. The improved venous tone helps 
to sustain arterial pressure and cardiac output to near normal val-
ues. Hence, there is the advantage that the phenylephrine dosage 
reduces, or eliminates, the need for fluid supplementation [51, 52]. 
There is little if any effect of low dose phenylephrine on arteriolar 
resistance. The consistent fall in arterial pressure and cardiac out-
put together on induction of anesthesia occurs without alteration 
of SVR. This then is an important illustration of the fact that it is 
not SVR change which causes arterial pressure change, it is venous 
tone and hence arterial volume change which, at least in the short 
term, causes arterial pressure change.
b) The loss of some of the arterial blood volume to the veins is an 
unfortunate consequence of routine anaesthetic induction. How-
ever, intentional re-distribution of blood volume from the arteri-
al to the venous compartment has been introduced recently as an 
effective way of reducing arterial blood pressure, in patients with 
refractory hypertension. Use of the ROX coupler for hypertension 
[53] involves insertion of a 4mm diameter connection between the 
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femoral artery and femoral vein. Blood flow of around 1 litre per 
minute through this arteriovenous connection has been recorded, 
with consequent reductions in arterial volume and shift in the ar-
terial/venous volume relationship; i.e. an increase in venous vol-
ume. Arterial pressure is reduced very rapidly by this manoeuvre, 
as soon as the connection is established on the catheter lab table, 
although the extent of this reduction may be later modified. The 
paper of Lobo et al [54] shows, nevertheless, that useful pressure 
reduction persists for at least 6 months. 
c) The work of Sharpey-Shafer [34] on venous tone (Figure 12) 
illustrates the increase seen with removal of blood from the cir-
culation. With moderate haemorrhage, the fact that there is little 
or no fall in arterial pressure is compatible with the transfer of ve-
nous blood into the arterial compartment. This arises from the ba-
ro-reflex response to a reduced rate of rise of the arterial pressure 
waveform, which reduces the baro-receptor reflex, causing an in-
crease in sympathetically mediated venous tone, from contraction 
of muscle fibres in the walls.
In the same study, adrenaline, given intravenously also caused ve-
nous constriction. He also showed that the postural hypotensive 
effect of ganglion blocking drugs was predominantly due to venous 
rather than arteriolar dilatation. 
These studies illustrate the fact that arterial pressure depends on 
total blood volume and its distribution between arterial and ve-
nous compartments. 
Figure 12: Venous contraction increasing venous tone, with a large venesection in a 
normal subject:. The  increased venous tone with haemorrhage will transfer venous 
volume, via the heart, to the arterial  compartment, compensating for the loss of 
blood, thereby sustaining arterial pressure. From: Sharpey-Schafer with permission: 
copyright of BMJ Publishing Group Ltd
3.3.4. Venous Sympathetic Innervation, Venous Tone, Arterial 
Pressure  Changes and Independent Tissue Autoregulation
a) The idea that venous tone and arterial pressure will go together 
is supported by the finding that “venous tone is increased via auto-
nomic effector systems during the developmental stages of sponta-
neous hypertension [55]”. 
b) Studies of King and Fink [56] linked salt, angiotensin II, Mean 
Arterial Pressure (MAP) and raised Mean Circulatory Filling Pres-
sure (MCFP). Measurements were made on four groups of con-
scious rats, fed a normal (0.4%) or high (2%) NaCl diet to study the 
effects of chronic, low dose, angiotensin II on HR and MAP (their 
Figure 1), blood volume and MCFP (their Figure 2). Angiotensin 
II was infused for 14 days in both low and high salt diet rats. Two 
control groups, on normal or high NaCl diets, functioned as con-
trols. In Figure 13 data has been plotted for those on high NaCl 
receiving angiotensin II (150 ng per minute) for 14 days after a 3 
day control period. So, Figure 13 shows the control and test values 
for MCFP and MAP in the rats on the high NaCl diet. 
Figure 13: Measurements of MAP and MCFP made on conscious rats taking a high 
salt diet and infused with low dose angiotensin II (see text). The data comes from 
a paper by King and Fink (56). The upper panel is a histogram plot of values prior 
to infusion followed by 14 days on angiotensin II. It shows  increases of both MAP 
and MCFP. A regression line calculation through these values is shown in the lower 
panel. The strong correlation is compatible with a causal relation between MCFP 
and MAP.
The rise in MCFP is consistent with veno-constriction. The increase 
in MAP is consistent with the resultant transfer of venous volume 
into the arterial compartment. The way in which veno-constric-
tion is mediated is not clear. Certainly, the result in rats on low 
dose NaCl showed no consistent change in MCFP or MAP despite 
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receiving the same regime of continuous low dose angiotensin II. 
The result on high NaCl is strongly supportive of the fundamental 
dependency of arterial blood pressure on arterial blood volume. 
The precise measurements made in this paper included total circu-
latory blood volume. There was no change in total blood volume to 
account for the arterial pressure change, so the whole change was 
from venous to arterial re-distribution.
An important assertion in this paper’s introduction requires con-
sideration. "Increases in splanchnic sympathetic nervous system 
activity cause a translocation of blood toward the heart, increasing 
cardiac diastolic filling and cardiac output.” As pointed out earlier, 
the increase in venous tone means that the venous to arterial ratio 
has increased. As circulation continues there is a redistribution of 
blood volume – reduction on the venous side and augmentation on 
the arterial side. The larger volume in the arteries means there is a 
higher arterial pressure. Blood flow, normally, remains unchanged, 
so there is no increase in CO – yet another illustration of auto-reg-
ulation [25]. 
c) An example of maintenance of appropriate constant blood flow 
in the face of increased arterial pressure is provided by the response 
to a three minute autonomic testing manoeuvre. From supine the 
subject sits up and then has to maintain a straight back and keep 
his/her legs straight at right angles to his/her back. The manoeuvre 
is stressful and causes a progressive increase in arterial pressure 
Figure 14. The initial transient peak in CO is due to the use of back 
muscles during the effort of rising to the straight back position 
from supine, with the associated peak in VO2. Increased metabolic 
rate continues, at a more moderate level, but there is a steady, pro-
gressive, increase in MAP. CO remains at an increased, near steady 
value, appropriate to the steady, increased metabolic rate, despite 
the concurrent increase in MAP. Further (MAP driven) increase 
in CO, is prevented by the progressive increase in (SVR). Figure 14 
illustrates circulatory variables during this ‘sit up’ manoeuvre in a 
normal subject. 
This increase in SVR, after the ‘transient’ (brief peak in CO, dip in 
SVR etc) parallels the subsequent increase in MAP. This prevents 
futher increase in CO, otherwise expected from the MAP increase. 
This again is simply ‘auto-regulation’ mediated by the tissues. The 
Sit Up manoeuvre, described here, has been found to be a valuable 
addition to a set of other manoeuvres utilized to assess autonomic 
function [57].
d. The usual assumption to date has been that arterial pressure 
changes are caused by a rise in SVR whereas it is apparent that 
changes in SVR result from a tissue response to changes in pres-
sure. In Figure 14 the record of the ‘Sit Up’ manoeuvre showed 
MAP and SVR rising together. Since the causal relation for the 
apparent SVR-pressure correlation turns out to be opposite to the 
assumption to date, it is of interest to see whether MAP and SVR 
can behave differently. In Figure 15 we see the result of a second 
manoeuvre where the subject is stressed by a prolonged period 
sustaining a hand grip, squeezed at half their preceding maximum 
(brief attempt). MAP rises here but, in this case, SVR does not rise. 
As a consequence CO increases as a result of the increase in MAP. 
Figure 14: The ‘sit up’ manoeuvre – the subject rising from supine to a sitting up 
position, holding their back straight at right angles to straight horizontal legs. This 
gives rise, initially, to a large increase in metabolic rate and the initial peak in CO 
(red trace). For the rest of the manoeuvre CO remains near  constant with a more 
moderately increase metabolic rate. Following the initial transient, MAP (red line 
in black BP record) and SVR (green) rise in parallel; the increase in SVR opposes 
the effect of MAP on CO. The heart rate increase is concomitant with the increased 
CO, not causal. This trace is derived from a recording using LiDCOView Pro (LiD-
CO PLC, UK).
Figure 15: The record shows the changes which occur during sustained squeezing 
hand grip of half the maximum obtained (briefly) earlier. Despite the steady in-
crease in mean arterial pressure (MAP), SVR  does not follow it. Now CO increases 
while SVR barely changes during the manoeuvre – completed at the event mark 
(blue). 
3.3.5. Evidence from Measurement of Venous and Total Blood 
Volume 
Although hypertension is by definition abnormal, studies showing 
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changes which are associated with excess arterial pressure, sup-
port the notion that arterial pressure is related to venous pressure, 
venous wall tone and inversely related to venous volume. There 
were already several important such measurements quoted in the 
review of Safar and London [21]. Forearm venous tone had been 
shown to be increased in hypertension [their Ref 4]. Total blood 
volume had been shown to be normal or reduced in hypertension 
– a figure of 12% reduction in severe hypertension – all of which 
(reduction) must be venous – since arterial volume is expanded 
at higher arterial pressure [58]. These authors refer to three listed 
studies, showing higher central venous pressures, in patients with 
sustained essential hypertension, than were present in age and sex 
matched normal subjects. Since intra-thoracic volume has been 
found to be normal in essential hypertension, the predominant and 
significant reduction is in the ‘peripheral’ (systemic) portion of the 
venous volume. It is the reduced venous volume and increased ve-
nous pressure from increased venous wall tone which sustains the 
excess distribution of circulatory volume in the arteries, thereby 
sustaining hypertension. 
3.4. Excess Fixed Cerebral Vascular Resistance and Hyperten-
sion 
The normal adjustment of blood flow to a given tissue is, as point-
ed out in section 1, by control of arteriolar resistance. For cerebral 
blood flow this mechanism can fail, if there is sufficient abnormal 
resistance upstream of the tissue arterioles. If this occurs acutely it 
may result in inadequate local arterial pressure between the fixed 
upstream resistance and the arterioles. Auto-regulation of local 
blood flow will fail acutely generating cerebral tissue ischaemia. 
It has recently been shown that, under these circumstances, the 
consequent cerebral ischaemia causes stimulation of sympathetic 
output mediated by astrocytes. This is a new finding, where the 
mechanism is effectively an intra-cerebral baro-receptor [59]. The 
resulting systemic hypertension will give adequate arterial pressure 
between the fixed resistance and cerebral tissue arterioles enabling 
auto-regulation to sustain normal cerebral blood flow. Discovery 
of this phenomenon is the recent result of studies undertaken 
since an original hypothesis was put forward by John Dickinson, 
that narrowing of brain stem cerebral arteries from atheroma, re-
sulting in local ischaemia, could be the basis of hypertension. He 
had found a strong correlation between vertebral artery resistance 
and the ante-mortem blood pressure in cadavers [60]. He provid-
ed supportive evidence, in that the cerebral respiratory quotient 
in hypertensive patients and normal subjects differed; for normal 
subjects the cerebral respiratory quotient was 0.98 to 0.99 whereas 
for hypertensive subjects it was significantly lower, being close to 
0.91 [61]. 
The fact that brainstem hypo-perfusion and ischaemia were linked 
with hypertension in man and animals led to the suggestion that the 
excess vascular resistance and hypertension were causally linked, 
with, as yet, no idea of the likely mechanism; though it seemed 
inconsistent with the background theory of orthodox baro-recep-
tor function [62]. Brainstem hypoxia has since been confirmed in 
the spontaneously hypertensive rat, also known to have narrowed 
vertebral and basilar arteries [63, 64]. Increased cerebral vascular 
resistance occurs in more patients with hypertension than in con-
trols. This has been especially related to congenital vascular anom-
alies which include vertebral artery hypoplasia and incompleteness 
of the posterior vessels of the circle of Willis. These patients also 
exhibit a higher incidence of lacunar type cerebral infarcts [65]. 
Patients with coarctation of the aorta also exhibit these cerebral 
vascular anomalies and are hypertensive in 20 to 30% of cases af-
ter coarctation repair [66]. Here the situation is more complicated, 
because the arterial pressure above the coarctation (narrowing) is 
high pre-operatively, with ordinary arterial pressures in main sys-
temic vessels beyond the coarctation. The simplest argument is that 
the hypertension in the pre-coarctation segment of the aorta is due 
to the fixed resistance offered by the associated cerebral vascular 
anomalies. When the coarctation is repaired these fixed resistances 
are still in place. The mechanism of persistence of inadequate pres-
sure between the fixed resistance and arterioles gives the ischaemic 
stimulus to astrocytes, with sympathetic nerve stimulation result-
ing in hypertension. 
Mechanism operating where an abnormal fixed resistance is pres-
ent in the cerebral vascular pathway. 
The proposed mechanism is illustrated functionally in Figure 16
Figure 16: Diagramatic illustration of hypothesised percentage changes in cerebral perfusion values of  mean arterial pressure, resistance and cerebral blood flow (CBF) 
during passage of blood en-route from  cerebral input vessels to cerebral venous outflow. Normally the arterioles regulate cerebral vascular  resistance (Rcer) at the arte-
rioles thereby sustaining appropriate CBF in the face of normal arterial  pressures (in the auto-regulatory range). This is illustrated in the left panel with an event mark at 
the  timing/distance along the vascular pathway indicating the location of arteriolar resistance. The middle  panel shows the putative immediate result of a fixed upstream 
resistance. The new left hand event mark  indicates the timing/distance along the cerebral vascular pathway of the new fixed vascular resistance. The pressure drop from this 
fixed resistance results in a pressure between the fixed resistance and  arterioles which is below the auto-regulation range, Hence, CBF will be inadequate with an ischaemic 
stimulus to astrocytes. The right hand panel shows the expected longer term result re-instating normal CBF by means of the hypertensive increase in systemic arterial blood 
pressure, resulting from extra sympathetic stimulation of venous tone. Key: MAP maroon, Rcer orange/brown, CO blue. The event marks are each shown as a red triangle. 
Where both resistance and pressure (MAP) are the same the colour code for MAP (maroon) dominates.
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The acute phase of the introduction of a fixed cerebral upstream 
resistance is included here and is likely to be applicable to the acute 
onset of stroke. However, the end (adapted) result with associated 
systemic arterial hypertension will have resulted chronically, where 
the upstream resistance has been in place long term. In the acute 
phase, with normal arterial pressure the upstream resistance will 
cause an acute fall in local MAP (between here and the arterioles). 
The low MAP and high cerebral vascular resistance will cause local 
MAP, on the way to the arterioles, to fall to levels below the normal 
auto-regulatory range, with consequent reduction in CBF. The re-
sultant ischaemia stimulates astrocytes which in turn gives rise to 
increased venous tone from increase in sympathetic activity. The 
result is systemic hypertension.
3.5. Summary – Section 2 
Arterial blood pressure depends on arterial blood volume and 
compliance. Total blood volume and venous tone are the major 
determinants of arterial volume. The analysis and quoted measure-
ments establish that the sympathetic nervous innervation of the ve-
nous system is the major determinant of the distribution of blood 
volume between the venous and arterial compartments, and hence 
determines arterial blood pressure. 
This also means that changes in arterial blood pressure are particu-
larly influenced by changes in venous sympathetic activity. 
The property of tissues, i.e. that they determine the blood flow re-
quired to sustain appropriate oxygen delivery, means that tissue 
metabolic rate is the main determinant of arteriolar resistance. 
It means that blood flow and arterial pressure control are largely 
independent, and that there is probably constant but unchanging 
activity of the sympathetic innervation of arterioles under normal 
circumstances, and within moderate levels of physical activity. 
Recent work shows that high venous tone, and hence arterial pres-
sure, can result from the presence of abnormal, fixed, additional 
cerebral resistance, from atheroma or stroke. The fixed resistance 
is on the cerebral vascular pathway to the tissues, and can be re-
ferred to as ‘upstream’ of normal arteriolar resistance. Ischaemia 
of astrocytes, resulting in stimulation of the sympathetic, sustains 
hypertension [59]. Implifications of this finding are discussed in 
Section 3.
Concerning implications of section 2 on DO2 and section 2 on ar-
terial blood pressure the fact that circulatory physiology, described 
in sections 1 and 2, is so different from current understanding has 
major practical implications with regard to clinical management. 
For instance both noradrenalin and phenylephrine, at low dosages, 
have been mentioned as having a positive effect on increasing ve-
nous tone rather than arteriolar resistance [67, 68, 69].
A fundamental insight we have outlined is that changes in arterial 
pressure are mostly a result of changes in venous tone. This also 
means that one knows that a fall in arterial pressure, in the absence 
of haemorrhage, means that there has been a loss of some arterial 
volume to the venous side of the circulation. In the longer term 
total blood volume changes can alter arterial pressure. 
We are now in a position to ask some fundamental questions such 
as: 
1. How the precise adjustment of oxygen delivery, described in the 
first section is achieved; and 
2. How the reflex mechanisms which affect arterial pressure work, 
presumably on venous tone rather than arteriolar constriction. 
Also, 
3. The modes of action of pharmacological agents. 
As mentioned earlier, the recent study of Kaelin et al in demon-
strating the “pathway that directly signals oxygen levels in cells”, 
[18] should act as a major facilitator in answering question 1 above. 
The implications of a number of aspects of the findings outlined in 
sections 1 and 2 are considered further in section 3.
SECTION 3
4. Implications from the New Model of The Circulation: 
Tissue Control of DO2 and the Volume Basis of Arterial 
Blood Pressure. 
4.1. Independent Circulatory and Arterial Pressure Control and 
Disordered Mechanisms 
The novel conclusion of sections 1 and 2 is that both arterial blood 
pressure (cerebral and reflex control) and arterial blood flow (tissue 
control of the rate of oxygen delivery - DO2) are largely controlled 
independently of each other. Also, that the normal matching of 
DO2 to the rate of oxygen consumption (VO2) is the top priority of 
the circulatory system. 
The importance of the insights from sections 1 and 2 include the 
better understanding of these two main features of circulatory 
control, with the potential to mitigate serious deleterious effects 
both of disease and of therapeutic manoeuvres which interfere 
with the precise matching of DO2:VO2. The priority also applies to 
the inverse ratio – VO2/DO2 – or ‘oxygen extraction’. Its constancy 
is therefore a means of expressing the importance of the correct 
precisely controlled DO2. Section 1 gives specific values of oxygen 
extraction for heart, exercising skeletal muscle and brain. 
Both inadequate and excessive oxygen delivery are dangerous, with 
generation of excess Reactive Oxygen Species (ROS), especially su-
peroxide (O2•-) leading to inflammation with release of cytokines. 
For example, mismatch of DO2 with VO2 and build up of oxygen 
debt during anesthesia and surgery, has been associated with an 
increased incidence of complications and death. It is suspected that 
cognitive dysfunction following surgery is also from incurred oxy-
gen debt [70]. These problems in anesthesia, where complications 
result from generation of excess ROS, are discussed later. Excess 
plasma concentrations of ROS are also found in hypertension [71, 
72] and in diseases of non-hypertensive autonomic dysfunction, 
including chronic fatigue syndrome [73, 74].
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The reason for failure of DO2:VO2 precision matching lies in dis-
orders of the mechanisms controlling both arterial blood pressure 
and Systemic Vascular Resistance (SVR). Changes in arterial blood 
pressure, mediated mainly by changes in venous sympathetic activ-
ity, will give rise to changes in Cardiac Output (CO) unless there is 
corrective auto-regulation of SVR by the tissues. Changes in SVR 
will also cause changes in CO, proportional to changes in conduc-
tance (the inverse of SVR). These occur normally with exercise but, 
inappropriate change in SVR/conductance will upset DO2:VO2 
matching. We have shown that the normal increase in CO in mild 
to moderate exercise is virtually all driven by the increase in con-
ductance (reduction in SVR) [19] See Figure 17. 
Figure 17: Recordings of CO, MAP and conductance, expressed as a percentage 
of the rest values, showing the response to mild exercise for one minute. The blue 
trace shows the changes in cardiac output (CO%) during 1 minute of mild exercise. 
MAP% (maroon) average values show no basic change whereas the conductance 
(Cond%) profile (green) follows the CO profile closely. The onset and end of ex-
ercise are shown as red triangle markers. These findings confirm the appropriate 
tissue response; so lowering of arteriolar resistance (increase in conductance) is the 
driver of the CO increase.
Work in progress is showing abnormal changes in both arteri-
al blood pressure and SVR during mild exercise, in both hyper-
tension and chronic fatigue syndromes; with upset of oxygen ex-
traction (unpublished, work in progress). 
An important interaction between arterial blood pressure and the 
rate of cerebral oxygen delivery to the brain has recently been con-
firmed see (section 2). This involves hypertensive compensation 
for abnormal fixed resistances in the cerebral arterial pathway to 
the tissues [59]. 
4.2. Discussion 
How do individual tissues control their own oxygen supply? Ni-
tric oxide (NO) is clearly important, [75] since the normally pre-
cise cardiac DO2:VO2 matching is destroyed when NO synthesis 
is blocked with L-NNA (see section 1, Figure 5, analysis of data 
from Martinez et al) [13]. There is also an intimate relationship 
between NO and the potent ‘vaso-constrictor’ endothelin-1. It has 
been pointed out in section 2 that endothelin-1 is present in ve-
nous endothelium and participates in the determination of venous 
tone and hence arterial blood pressure [29, 30, 76]. It has also been 
shown that “NO contributes not only to the regulation of venous 
tone but also to resting venous tone in healthy human subjects 
[77]. ”Direct NO production in the skin by photolysis occurs with 
exposure to the UVA component of sunlight, and two major stud-
ies have shown this reduces arterial blood pressure in young nor-
mal subjects [78, 79]. 
Apart from there being a role for NO, the question remains as to 
‘how tissues manage the precise matching of DO2 to VO2. The re-
cent advance in the discovery of: “a pathway that directly signals 
oxygen levels in cells” is mentioned at the end of section 2 [18]. It is 
likely to greatly facilitate finding out the means by which the body 
ensures the precision DO2:VO2 matching – constancy of oxygen 
extraction. A part of the difficulty in understanding the required 
mechanism is to see how the demand at the tissues operates the 
upstream changes in arteriolar resistance and there is a question 
here as to the degree to which capillary recruitment can act in de-
termining the appropriate input resistance to the tissue concerned. 
A further question concerns total blood volume; consisting of 
the total red cell mass and the total volume of plasma. Much is 
understood about regulation of features of both components. For 
red cells determinants of haemoglobin include arterial oxygen ten-
sion (PO2) and erythropoietin. For the plasma component of to-
tal blood volume considerable explanatory detail of its electrolyte 
and other components is available. To understand the control and 
maintenance of total blood volume however, requires knowledge 
of the mechanisms determining total plasma volume, and the way 
in which the combined red-cell and plasma volume – total blood 
volume – is determined.
As regards the determination of electrolyte content, features de-
termining actual, active, ‘concentration’ – osmolality – include re-
ceptors in gut, portal vein and in the brain [80]. In regard to this, 
the action of water drinking in hypotensive patients with severe 
autonomic failure results in remarkably large increases in systolic 
pressure, not seen in young controls, but in mild terms in the elder-
ly. The responses involve sympathetic stimulation with increased 
noradrenalin (nor epinephrine) levels. “Drinking water can pro-
vide a rapid relief of symptoms resulting from orthostatic hypo-
tension in autonomic failure patients” [81]. Further information 
about how water drinking can affect arterial blood pressure comes 
from studies in a mouse model of baro-receptor deficiency [82]. 
The authors adopted this model because “the effect of water drink-
ing was greatest in individuals with impaired baroreflex buffering". 
They were able to demonstrate a large pressor response from du-
odenal water infusion, which was eliminated by administration of 
the α1 adreno-receptor antagonist prazosin before water infusion. 
They were able to show that the receptors belonged to the transient 
receptor potential cation channel family (TRPV) by utilizing do-
pamine ß-hydroxylase knockout mice. When these mice were in-
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fused there was no significant response. Another important finding 
was the exclusion of plasma volume expansion as the mechanism. 
Infusing a saline bolus produced only a small, temporary, spike in 
pressure in contrast to the longer lasting increase from duodenal 
water loading [82].
Since the increases in arterial pressure from water ingestion/load-
ing are not simply from modest expansion of the total blood vol-
ume, and since arterial pressure is related to arterial volume, the 
mechanism, from our analyses, is consistent with an increase in 
venous tone. This is consistent with the strong sympathetic stimu-
lation shown to occur with water ingestion [82].
4.3. Vasodilation and Vasoconstriction 
These terms have been conventional ways of describing presumed 
actions on the circulation which we propose require revision. For 
example, the correlation between SVR and arterial pressure (in 
particular the mean value, MAP) has meant that it has been as-
sumed that a ‘vaso-dilator’ will lower SVR and that this will result 
in a lowering of arterial pressure. However, when a medication 
does lower arterial pressure it has caused a shift of some of the ar-
terial blood volume into the venous side of the circulation, as a 
result of dilatation of the venous system (section 2). With normal 
tissue function, and in response to reduced perfusion pressure, the 
individual tissues respond by lowering input resistance, thereby 
keeping oxygen delivery (DO2) at precisely the correct original lev-
el. This compensation avoids the reduction in DO2 and resulting 
ischaemia which would otherwise occur from reduced pressure 
alone. So this is veno-dilation with arteriolar relaxation secondary 
to reduced arterial blood pressure. 
Similarly, an increase in arterial pressure means there has been 
a shift of some venous blood into the arterial tree. The tissue re-
sponse is to increase local input resistance preventing excess blood 
flow and DO2. This is veno-constriction with increased resistance 
at the arterioles secondary to increased arterial blood pressure. 
These adjustments in arterial blood pressure with responses sus-
taining appropriate blood flow are descriptions of the mechanisms 
behind ‘auto-regulation of blood flow’. These normal compensa-
tory adjustments to resistance offered at arterioles occur inde-
pendently of arteriolar sympathetic innervation activity, which it 
has been argued, in section 2, is normally constant. These changes 
illustrate the fact that SVR changes are a tissue response to MAP 
changes from venous/arterial volume shifts. This, it must be em-
phasized corrects the current idea that arterial pressure changes 
result from sympathetic driven changes in SVR. A ‘vasodilator’ is 
more specifically a ‘venodilator’. A ‘vasoconstrictor’ is more specifi-
cally a venoconstrictor. These are terms which are preferable to the, 
now ambiguous, terms vasodilator’ and vasoconstrictor’. 
4.4. Venous and Arteriolar Sympathetic Innervation 
Excess DO2 is harmful [2, 15] and normally prevented. Both excess 
and inadequate DO2 represent unacceptable non-constancy of ox-
ygen extraction and result from abnormal action of either venous 
or arteriolar sympathetic innervation. 
The very different roles of the sympathetic innervation of the ve-
nous system and the arteriolar system, require further clarification. 
It is important to find out more about the central organization of 
venous versus arteriolar central connections. Knowledge of what 
controls each type, i.e. venous and arteriolar sympathetic regu-
lation, is likely to be of considerable practical value and will pre-
sumably require revision of pharmacological thinking. The venous 
sympathetic innervation is highly dependent on the baro-receptor 
reflex. Work is quoted in section 2 on the effects of baro-receptor 
stimulation and inhibition of venous tone. Detailed reasoning is 
given in section 2 for the likely constancy of arteriolar sympathetic 
activity (except under emergency situations and disease). See later 
for further discussion of new work on the maintenance of cerebral 
blood flow in hypertension. 
4.5. Consideration of Venous Tone in Anesthesia 
Several studies have now highlighted the fact that induction of an-
esthesia, with commonly used agents, dilates the venous system. At 
first it was assumed one knew this because of increased variability 
of stroke volume and or pulse-pressure, once the patient was on 
intermittent positive pressure ventilation. Recent work does, how-
ever, confirm dilatation of the venous system during induction of 
anesthesia [69]. The fact that this venous dilatation was accompa-
nied by a fall in arterial pressure but not in SVR is consistent with 
the argument of section 2 – that dilatation of the venous system is 
the mechanism of the fall in arterial pressure (specifically MAP) 
with induction of anesthesia. The alternative cause of lowered pres-
sure is actual loss of blood volume – usually haemorrhage – but 
occasionally from other factors. It is commonly assumed that the 
fall in MAP results from the concurrent fall in cardiac output [83]. 
However, the fall in CO is largely due to the fall in MAP, which, in 
turn, is due to loss of arterial volume into the dilated venous sys-
tem. Clinical practice has shown that the venodilation of anesthetic 
induction can be minimized by infusing low dose phenylephrine 
over the pre-induction period and continuing the infusion during 
induction and maintenance of anesthesia [84, 85]. Despite the fact 
that the infusion begins before induction there is no change in CO 
until induction starts (Figure 18 upper panel). In the absence of 
phenyephrine MAP and CO fall further (Figure 18 lower panel). 
VO2 under anesthesia is said typically to be at around 85% of the 
pre-induction value. The extent to which in CO falls below 85% of 
the control value will determine the buildup of oxygen debt caused 
by decreased DO2 and hence the degree of tissue ischaemia [86]. 
Figure 18 illustrates the likelihood that there will be far less tissue 
ischaemia with low dose phenylephrine, than without. Since, most 
anesthesia in the UK is conducted from an anesthetic room, cardi-
ac output is not monitored (if at all) until the patient is in the op-
erating theatre, and is already anaesthetized with lowered CO and 
DO2. Hence, most patients are probably ischemic from the earliest 
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stages of anesthesia. At present, however, the emphasis has been 
on arterial blood pressure and avoidance of hypotension rather 
than sustaining adequate CO. The pre-induction (actual or nom-
inal) DO2 (from actual or nominal CO and Hb) is the reference 
value required during surgery and depends on accurate trending 
of the CO estimate. DO2 may well be considerably compromised, 
from the start of the operative period, where the appropriate CO is 
unknown. The high incidence of inadequate DO2 post induction, 
continuing throughout surgery and into the post operative period, 
is the reason for buildup of an oxygen debt and the high incidence 
of complications and (often delayed) death [86]. A high proportion 
of patients require care postoperatively in either a high dependen-
cy unit or in intensive care for a period prior to returning to their 
original ward. See section 1 for incidence of inflammatory markers 
in anesthesia.
Figure 18: The values of CO, Conductance (reciprocal of SVR) and mean arterial 
pressure (MAP) are each shown as a percentage of the mean resting, pre-induction, 
value. Heart rate (HR) values are as recorded. Upper panel: Intra-venous infusion 
of low dose phenylephrine was begun while the patient was awake, prior to intra-
venous administration of anaesthetic. Induction with anaesthetic (propofol) was 
followed by a fall of both MAP and CO towards around 75% to 80% of awake con-
trol values. 
Lower panel: No phenylephrine was given to this patient. There is again a fall of 
both MAP and CO, but this time to around 60% to 70% of awake control values.
Sensitivity, to the agents used in anesthesia, has been shown to vary 
considerably, especially in older patients. The effect of a particular 
dosage – usually satisfactory especially in younger patients may 
result in anesthesia being too light or too deep [87]. Studies have 
shown that processed EEG monitoring enables titration of the in-
duction agent into a safe range – ‘safe’ meaning avoiding aware-
ness or an excessive fall in arterial pressure and CO. Sustaining the 
appropriate depth of anesthesia facilitates appropriate regulation 
of DO2. The inclusion of measurement of cerebral oxygenation 
as indicated by rSO2 is an indication as to whether overall DO2 is 
adequate [88]. Where cerebral oximetry shows a fall in oxygen-
ation, the manoeuvres to increase venous tone or administration 
of intra-venous fluid, in the absence of haemorrhage, will usually 
correct rSO2 CO and DO2. Utilization of the measurement of CO, 
depth of anesthesia and cerebral oxygenation has been referred to 
as multimodal monitoring and has minimized side effects, [85, 68]. 
4.6. Causality in the Circulation 
The investigations which led to the insight in the first section, that 
tissues determine their own optimum rate of DO2, puts the cause 
of blood flow and hence CO firmly at the tissue level. Blood flow 
and DO2 are determined by tissue VO2 which, in turn, has its own 
determinants for different tissues. For skeletal muscle and the heart 
VO2 is related to muscular activity. For the brain there is constant 
local variation in VO2. Less obvious are the determinants of bone 
and skin VO2. For the gastro-intestinal tract VO2 follows the prog-
ress of digestion of a meal, including the processes of absorption, 
secretion and smooth muscle contraction. The location in the gut 
of the meal under digestion is accompanied by proportional in-
creases in blood supply and hence DO2. As mentioned earlier, the 
means by which appropriate vascular resistances and hence DO2 
are determined are, as yet, unknown. 
Although tissue activity normally determines input resistance the 
ambient arterial pressure is the second factor determining blood 
flow. We therefore have two factors which determine blood flow. 
Changes in blood flow will occur when either factor is changed. 
An increase in arterial pressure, without any change in resistance, 
will produce a precisely proportional increase in blood flow. An 
increase in conductance (fall in resistance) will also produce a 
directly proportional increase in blood flow if there is no change 
in arterial blood pressure. In normally functioning tissues factors 
which produce a need for more blood flow include: 
1. an increase in VO2; 
2. a decrease in arterial oxygen content 
Within a moderate range of these changes tissue action results in 
an appropriate change in conductance; there is no interference 
from inappropriate changes in arterial pressure. A change in the 
sympathetic supply to either veins or arterioles would result in in-
appropriate DO2. Where there are changes in arterial blood pres-
sure, the effects are systemic and apply to all tissues. Resistance/
conductance changes are applicable to a particular tissue. In exer-
cise, the change in VO2, though specifically from resistance/con-
ductance changes in skeletal muscle, are large enough for the blood 
flow change to show as a change in cardiac output. 
4.7. Oxidative Stress in Heart Failure 
Since CO is lower than appropriate in heart failure it is worth 
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re-examining the background to this inadequacy. Section 1 points 
out that individual tissues adjust their input resistance such that 
DO2 is appropriate – at the correct DO2:VO2 ratio. All individu-
al tissues therefore determine their fraction of the whole venous 
return. This means that CO is normally a simple addition of all 
these separately determined rates of blood flow. Hence, we have 
to assume that heart failure represents the situation when, despite 
the normal capability to adjust individual tissue blood flows, the 
total is too great for the heart to manage. Now we have a situation 
where tissue blood flow demand is not met. The conclusion is that 
all tissues are now in a state of oxidative stress. Hence, the source of 
ROS will mainly be from peripheral tissues rather than the heart. 
It seems this is not the conclusion drawn in papers on oxidative 
stress in heart failure, since they all refer to the effect of the cardiac 
generated ROS, or at least the effect of ROS on the heart [89, 90, 
91]. This may mean an unfortunate failure to hypothesise about re-
lief of systemic tissue oxidative stress. This suggests the hypothesis 
that it may be possible to achieve adequate DO2 in a failing heart if 
one can increase the carriage of oxygen. This could readily be test-
ed with sustaining a modest increase in inspired oxygen. Another 
means of increasing arterial oxygen content (CaO2) is the trick – 
used illegally by some racing cyclists – by provision of an increased 
haematocrit. Despite the assumption, often made, that increased 
haematocrit means increased viscosity and more cardiac work, the 
control of arteriolar resistance by the tissues, seems likely to negate 
such a potential negative effect. It seems worth some investigation 
in view of the hypothesised clinical benefit. 
4.8. Implications of the New Findings on Fixed Intra-Cerebral 
Resistance and Refractory Hypertension 
Section 2 discusses the study of Nephtali et al which has shown 
that abnormal intra-cerebral vascular resistance gives rise to hy-
pertension, via intra-cerebral baroreceptor action by astrocytes 
[59]. This helps to explain the refractoriness of hypertension in 
a proportion of hypertensive patients. Hypertension facilitates 
adequate Cerebral Blood Flow (CBF) since, with high systemic 
pressure, the reduction in intra-cerebral blood pressure, following 
the abnormal fixed resistance, is high enough to drive a normal 
CBF. The examples of this fixed intra-cerebral resistance are ver-
tebro-basilar atheroma or, in genetically hypertensive rats narrow-
ing of these vessels; also, some patients have abnormal anatomical 
variants of the circle of Willis. Also, in section 2 we discuss carot-
id endarterectomy. It seems the narrowed vessels also constitute a 
major fixed resistance en route to the brain. It was pointed out that 
arterial blood pressure is usually high in patients requiring carot-
id endarterectomy. Hence, the hypertension is probably from the 
intra-cerebral astrocyte mediated baroreceptor effect. In patients 
whose sinus nerve remains intact after carotid endarterectomy ar-
terial blood pressure falls, often to the normal range, whereas with 
loss of sinus nerve function arterial blood pressure changes very 
little. So, the compensation by astrocyte action, raising arterial 
blood pressure, remains if sinus nerve function is absent. It seems 
probable, as a result, that the correct baro-receptor action requires 
both the orthodox baro-receptor input via the sinus nerve, as well 
as that provided by astrocyte action. 
Since both the orthodox baroreceptors and the newly described 
intra-cerebral baro-receptor function are linked, we may assume 
they together constitute an overall baro-receptor mechanism. This 
seems to mean that the universal tissue priority of appropriate DO2 
has maximum priority for the brain, with the more fully described 
baro-receptor system acting as the link between arterial blood 
pressure control and tissue oxygen supply. 
5. Conclusion 
The results of sections 1 and 2 are that: 
• Cardiac output is normally determined independently by the tis-
sues such that individual tissue rates of oxygen delivery are appro-
priate to that tissue; 
• Arterial blood pressure is normally determined independently by 
means of reflex control of the sympathetic nervous system as well 
as humoral influences, particularly by adjustment of venous tone 
and/or the whole circulatory blood volume, such that the arterial 
pressure is determined by the resulting arterial blood volume. 
• Failure of appropriate oxygen delivery will give rise to excess Re-
active Oxygen Species (ROS) with inflammation and damage to 
tissues. 
6. Consideration of the Implications of Sections 1 (DO2)
and 2 (BP) in Section 3
1. They highlight the prime importance of matching DO2 to VO2 
and the potential for disease or medical intervention to interfere 
with it. The result of impaired DO2:VO2 matching, equivalent to 
abnormal tissue oxygen extraction, is tissue ischaemia with release 
of excess reactive oxygen species. This can lead to complications, 
and in severe cases, death. 
2. The complete revision of the basis of arterial blood pressure de-
termination has profound implications of fuller physiological un-
derstanding and new insights into patho-physiologic disorders of 
pressure regulation. 
3. Recent discovery of the mechanism behind systemic hyperten-
sion resulting from fixed cerebral resistances shows that protection 
of cerebral blood flow involves both tissue regulation and pressure 
regulation. This is the particular instance where, in the protection 
of blood flow and oxygen delivery to cerebral tissues, blood flow 
and pressure regulation are interdependent. 
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